Late last week AMP added a number of positions to its portfolio and sold a number of shares in other positions as well:
1.) Sold all of its remaining positions in CYTR, DBVT, MACK, and VSAR
2.) Started an initial position in GlycoMimetics (GLYC)
3.) Added to its position in ARRY
4.) Started a position in Regulus Therapeutics (RGLS)
5.) Continued to trim its position in NKTR